BioXcel Therapeutics $9.75M Class
Other
1
Settlement
$10M
Total Paid
2026
Last Settled
Based on 1 class action settlement in our database, BioXcel Therapeutics $9.75M Class earns a grade of D on corporate accountability.
D
Grade
58/100
Grade Breakdown
📊
Settlements on Record
1
30% of grade
💰
Total Settlement Amount
$9.8M
25% of grade
⚠️
Severity Score
35/100
20% of grade — higher is better
📅
Recency Score
15/100
15% of grade — recent settlements hurt more
All Settlements Involving BioXcel Therapeutics $9.75M Class
BioXcel Therapeutics $9.75M Class Action Settlement
Investors who bought BioXcel Therapeutics stock between March 9 and June 28, 2023, may be eligible to claim a cash payment from a class action settlement.
Amount: $9,750,000
Deadline: Jun 30, 2026
🔔
Watch BioXcel Therapeutics $9.75M Class
Get notified when new settlements involving BioXcel Therapeutics $9.75M Class are filed or when their grade changes.
Set Up Alert